A122310 Share Price Performance
Recent A122310 News & Updates
No updates
Genoray Co., Ltd. Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -307.86
- Gross Margin
- 37.17%
- Net Profit Margin
- -3.58%
- Debt/Equity Ratio
- 23.3%
Genoray Co., Ltd. Competitors
About A122310
- Founded
- 2001
- Employees
- 346
- CEO
- WebsiteView website
Genoray Co., Ltd. engages in the research, development, manufacture, and sale of medical and dental x-ray devices in South Korea. It offers C-ARM and mammography medical x-ray devices; and 2D, 3D, ENT, and IOS/IOX dental x-ray devices, as well as related maintenance and repair services. The company also exports its products to approximately 80 countries worldwide. Genoray Co., Ltd. was founded in 2001 and is headquartered in Seongnam-si, South Korea.
South Korean Market Performance
- 7 Days: 1.5%
- 3 Months: 24.6%
- 1 Year: 13.5%
- Year to Date: 32.5%
The market is up 1.5% over the last week, with the Information Technology sector leading the way, up 5.3%. In the last year, the market has climbed 14%. Earnings are forecast to grow by 21% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading